MLKL Recombinant Rabbit Monoclonal Antibody [SA40-04]
Usd: 385 Special Discount
Specification
Safety datasheet
Overview
Product Name
MLKL Recombinant Rabbit Monoclonal Antibody [SA40-04]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within Human MLKL aa 333-471 / 471.
Species Reactivity
Human, Mouse
Validated Applications
WB, IHC-P, IF-Cell, FC, IF-Tissue
Molecular Weight
Predicted band size: 54 kDa
Positive Control
HUVEC cell lysate, HT-29 cell lysate, HeLa cell lysate, THP-1 cell lysate, U-937 cell lysate, K-562 cell lysate, NIH/3T3 cell lysate, HeLa, HT-29, human tonsil tissue.
Conjugation
unconjugated
Clone Number
SA40-04
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:5,000-1:10,000
-
IHC-P
-
1:500-1:2000
-
IF-Cell
-
1:100
-
FC
-
1:1,000
-
IF-Tissue
-
1:500-1:1,000
Target
Function
Mixed lineage kinase domain like pseudokinase (MLKL) is a protein that in humans is encoded by the MLKL gene. This gene belongs to the protein kinase superfamily. The encoded protein contains a protein kinase-like domain; however, is thought to be inactive because it lacks several residues required for activity. This protein plays a critical role in tumor necrosis factor (TNF)-induced necroptosis, a programmed cell death process, via interaction with receptor-interacting protein 3 (RIP3), which is a key signaling molecule in necroptosis pathway. Inhibitor studies and knockdown of this gene inhibited TNF-induced necrosis.
Background References
1. Martens S et al. MLKL in cancer: more than a necroptosis regulator. Cell Death Differ. 2021 Jun
2. Liu S et al. MLKL polymerization-induced lysosomal membrane permeabilization promotes necroptosis. Cell Death Differ. 2024 Jan
Sequence Similarity
Belongs to the protein kinase superfamily.
Post-translational Modification
Phosphorylation by RIPK3 induces a conformational switch that is required for necroptosis. It also induces homotrimerization and localization to the plasma membrane.
Subcellular Location
Cytoplasm, Cell membrane, Nucleus.
Synonyms
9130019I15Rik antibody
FLJ34389 antibody
hMLKL antibody
Mixed lineage kinase domain like antibody
Mixed lineage kinase domain like protein antibody
Mixed lineage kinase domain-like protein antibody
Mlkl antibody
MLKL_HUMAN antibody
Images
-
☑ Relative expression (RE)
Western blot analysis of MLKL on different lysates with Rabbit anti-MLKL antibody (ET1601-25) at 1/5,000 dilution and competitor's antibody at 1/1,000 dilution.
Lane 1: HUVEC cell lysate (20 µg/Lane)
Lane 2: HT-29 cell lysate (20 µg/Lane)
Lane 3: HeLa cell lysate (20 µg/Lane)
Lane 4: THP-1 cell lysate (20 µg/Lane)
Lane 5: U-937 cell lysate (20 µg/Lane)
Lane 6: K-562 cell lysate (low expression) (20 µg/Lane)
Lane 7: NIH/3T3 cell lysate (20 µg/Lane)
Predicted band size: 54 kDa
Observed band size: 54 kDa
Exposure time: 1 minute 2 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1601-25) at 1/5,000 dilution and competitor's antibody at 1/1,000 dilution were used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Knockdown (KD)
Western blot analysis of MLKL on different lysates with Rabbit anti-MLKL antibody (ET1601-25) at 1/5,000 dilution.
Lane 1: Hela-si NT cell lysate (10 µg/Lane)
Lane 2: Hela-si MLKL cell lysate (10 µg/Lane)
Predicted band size: 54 kDa
Observed band size: 54 kDa
Exposure time: 3 minutes 20 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
ET1601-25 was shown to specifically react with MLKL in Hela-si NT cells. No band was observed when Hela-si MLKL samples were tested. Hela-si NT and Hela-si MLKL samples were subjected to SDS-PAGE. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary antibody (ET1601-25, 1/5,000) and Loading control antibody (Rabbit anti-GAPDH, ET1601-4, 1/10,000) were used in 5% BSA at 4 ℃ overnight. Goat Anti-rabbit IgG-HRP Secondary Antibody (HA1001) at 1:50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of HeLa cells labeling MLKL with Rabbit anti-MLKL antibody (ET1601-25) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-MLKL antibody (ET1601-25) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of HT-29 cells labeling MLKL with Rabbit anti-MLKL antibody (ET1601-25) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-MLKL antibody (ET1601-25) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of HT-29 cells labeling MLKL.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1601-25, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Application: Immunohistochemistry (IHC-P)
Species: Human
Tissue: Tonsil
Sample: Paraffin-embedded section
Antigen retrieval: Heat-mediated, Tris-EDTA buffer (pH 9.0), 20 minutes at 95℃.
Wash buffer: 1× TBST
Endogenous peroxidase blocking: 3% H₂O₂, 10 minutes at room temperature.
Blocking: 1% BSA + 10% normal goat serum, 10 minutes at room temperature.
Primary antibody: ET1601-25, 1/2,000, 1 hour at room temperature.
Secondary antibody: HA1119, 20 minutes at room temperature. -
Application: Immunofluorescence (IF-tissue)
Species: Human
Tissue: Tonsil
Sample: Paraffin-embedded section
Antigen retrieval: Heat-mediated, Tris-EDTA buffer (pH 9.0), 20 minutes at 95℃.
Wash buffer: 1× PBS
Endogenous peroxidase blocking: 3% H₂O₂, 10 minutes.
Blocking: 1% BSA + 10% normal goat serum, 10 minutes at room temperature.
Primary antibody: ET1601-25, 1/1,000, overnight at 4℃.
Secondary antibody: Goat Anti-Rabbit IgG (iFluor™ 488, HA1121), 1.5 hours at room temperature.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Nlrp12-driven PANoptosis exacerbates liver injury in ConA-induced autoimmune hepatitis
Journal: Genes And Immunity
DOI: 10.1038/s41435-026-00386-2
IF: 4.5
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
RIPK3/MLKL-mediated necroptosis promotes hepatic inflammation in chronic arsenic exposure through drinking water
Journal: Food And Chemical Toxicology
DOI: 10.1016/j.fct.2026.116020
IF: 3.5
Application: WB
Reactivity: Mouse
Publish date: 2026 Feb
-
Molybdenum and cadmium co-induced apoptosis and necroptosis via activating endoplasmic reticulum stress and upregulating Caspase-8 expression in duck hepatocytes
Journal: Poultry Science
DOI: 10.1016/j.psj.2026.106683
IF: 4.2
Application: WB
Reactivity: Duck
Publish date: 2026 Feb
-
MLKL PARylation in the endothelial niche triggers angiocrine necroptosis to evade cancer immunosurveillance and chemotherapy
Journal: Nature Cell Biology
DOI: 10.1038/s41556-025-01740-8
IF: 19.1
Application: WB,IP,CoIP
Reactivity: Human
Publish date: 2025 Sept
-
Targeted inhibition of MLKL-mediated necroptosis attenuates chronic arsenite exposure-induced lung injury
Journal: Ecotoxicology And Environmental Safety
DOI: 10.1016/j.ecoenv.2025.119216
IF: 6.1
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Oct
-
Activation of ZBP1/RIPK3/MLKL-Dependent Necroptosis by Pseudorabies Virus Restricts Viral Infection in BV2 Microglia Cells
Journal: Transboundary and Emerging Diseases
DOI: 10.1155/tbed/8510846
IF: 3
Application: WB
Reactivity: Mouse
Publish date: 2025 Oct
-
Targeting the MLKL–F-actin–NLRP3 Axis Attenuates Arsenic-Induced Myocardial Necroinflammation
Journal: Food And Chemical Toxicology
DOI: 10.1016/j.fct.2025.115861
IF: 3.5
Application: IHC
Reactivity: Mouse,Rat
Publish date: 2025 Nov
-
Enhanced oral nanomedicine utilizing biomineralized oncolytic virus for synergistic gastrointestinal cancer therapy
Journal: Materials Today Bio
DOI: 10.1016/j.mtbio.2025.102583
IF: 10.2
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Reduction of D2 receptors on microglia leads to ZBP1-mediated PANoptosis of mPFC in Parkinson's disease depression mice
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.114809
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2025 May
-
Role and mechanism of piR-0228 targeting RIPK1 to regulate vascular remodeling and aortic dissection
Journal: Atherosclerosis
DOI: 10.1016/j.atherosclerosis.2025.120459
IF: 5.7
Application: WB
Reactivity: Mouse
Publish date: 2025 Jul
-
Engineered Cell Membrane Vesicles Loaded with Lysosomophilic Drug for Acute Myeloid Leukemia Therapy via Organ-Cell-Organelle Cascade-Targeting
Journal: Biomaterials
DOI:
IF: 12.8
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
Engineered Cell Membrane Vesicles Loaded with Lysosomophilic Drug for Acute Myeloid Leukemia Therapy via Organ-Cell-Organelle Cascade-Targeting
Journal: Biomaterials
DOI: 10.1016/j.biomaterials.2025.123091
IF: 12.9
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
Staphylococcus aureus reprograms CASP8 (caspase 8) signaling to evade cell death and Xenophagy
Journal: Autophagy
DOI: 10.1080/15548627.2025.2483887
IF: 14.6
Application: WB
Reactivity: Cow
Publish date: 2025 Apr
-
Methyl 3,4-dihydrobenzoate attenuates muscle fiber necroptosis and macrophage pyroptosis by regulating oxidative stress in inflammatory myopathies
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.114608
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2025 Apr
-
MLKL triggers NLRP3 activation in sodium arsenite-induced myocardial necroinflammation
Journal: Toxicology
DOI: 10.1016/j.tox.2025.154132
IF: 4.8
Application: WB,IHC-P
Reactivity: Mouse
Publish date: 2025 Apr
-
ASFV infection induces macrophage necroptosis and releases proinflammatory cytokine by ZBP1-RIPK3-MLKL necrosome activation
Journal: Frontiers In Microbiology
DOI: 10.3389/fmicb.2024.1419615
IF: 4
Application:
Reactivity:
Publish date: 2024 Jun
-
Aurantiamide mitigates acute kidney injury by suppressing renal necroptosis and inflammation via GRPR-dependent mechanism
Journal: International Immunopharmacology
DOI:
IF: 4.8
Application: WB
Reactivity: Human
Publish date: 2024 Aug
-
Cpd-A1 alleviates acute kidney injury by inhibiting ferroptosis
Journal: Acta Pharmacologica Sinica
DOI:
IF: 8.2
Application: WB
Reactivity: Mouse
Publish date: 2024 Apr
-
Targeting Endothelial Necroptosis Disrupts Profibrotic Endothelial–Hepatic Stellate Cells Crosstalk to Alleviate Liver Fibrosis in Nonalcoholic Steatohepatitis
Journal: International Journal Of Molecular Sciences
DOI:
IF: 5.6
Application: WB
Reactivity: Mouse
Publish date: 2023 Jul
-
RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2022.109262
IF: 5.714
Application: WB
Reactivity: Human,Mouse
Publish date: 2022 Sept
-
Interferon-mediated repression of miR-324-5p potentiates necroptosis to facilitate antiviral defense
Journal: EMBO Reports
DOI:
IF: 8.807
Application: WB
Reactivity: Human
Publish date: 2022 Jun
-
Hypothermia Inhibits Cerebral Necroptosis and NOD-Like Receptor Pyrin Domain Containing 3 Pathway in a Swine Model of Cardiac Arrest
Journal: Journal Of Surgical Research
DOI:
IF: 2.194
Application: WB
Reactivity: Pig
Publish date: 2019 Dec